Document is current
Any future updates will be listed below
-
Authors
Chernyak, Victoria
Tang, An
Do, Richard K. G.
Kamaya, Aya
Kono, Yuko
Santillan, Cynthia S.
Fowler, Kathryn J.
Bashir, Mustafa R.
Cunha, Guilherme Moura
Fetzer, David T.
Kielar, Ania
Lee, James T.
Mendiratta-Lalla, Mishal
Sirlin, Claude B. https://orcid.org/0000-0002-6639-9072
,
-
Funding
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé (34939)
- License Information
-
More Information
Article History
Received: 16 January 2022
Revised: 18 March 2022
Accepted: 22 March 2022
First Online: 7 April 2022
Declarations
:
: The scientific guarantor of this publication is Dr. Claude B. Sirlin.
: The authors of this manuscript declare relationships with the following companies:Victoria Chernyak: Bayer consultantAn Tang: Speaking honorarium from Eli Lilly. Equipment loan from Siemens HealthineersRichard K.G. Do: Bayerconsultant; GE Healthcare consultantAya Kamaya: Elsevier book royaltiesYuko Kono: Research support from GE Healthcare, Bracco, Canon Medical Systems Inc. Lantheus Medical Imaging; Grant support: NIH 1R01CA194307, NIH 1R01CA2Cynthia S. Santillan: Consultant - Alimentiv Clinical Research (unrelated to liver imaging)Kathryn J. Fowler: Grant support GE, Bayer, Pfizer, Median; institutional consulting: GE; personal consulting: Bayer, epigenomicsMustafa R. Bashir: Research support to institution (federal): 5U01-DK061713-19, 1R01CA249765-01. Research support to institution (industry): Carmot Therapeutics, Corcept Therapeutics, Diabetes & Endocrinology Consultants, Madrigal Pharmaceuticals, Metacrine Inc, NGM Biopharmaceuticals, Pinnacle Clinical Research, ProSciento Inc, Siemens HealthineersGuilherme Moura Cunha: NoneDavid T. Fetzer: Advisory Board, Philips Healthcare; Research Support: GE Healthcare, Philips Healthcare, Siemens HealthineersAnia Kielar: NoneJames T. Lee: NoneMishal Mendiratta-Lalla: NoneClaude B. Sirlin: Dr. Sirlin reports grants from Bayer, GE, Gilead, Pfizer, Philips, Siemens; lab service agreements with Enanta, Gilead, ICON, Intercept, Nusirt, Shire, Synageva, Takeda; institutional consulting for BMS, Exact Sciences, IBM-Watson, Pfizer; Persona consulting for Blade, Boehringer, Epigenomics; receipt of royalties and/or honoraria from Medscape and Wolters Kluwer; ownership of stock options in Livivos; unpaid advisory board position in Quantix Bio
: No complex statistic methods were necessary for this paper.
: Informed consent was not required for this consensus statement.
: Institutional Review Board approval was not required for this consensus statement.
: • not applicable• not applicable• multicentre study
